Yang S Y, Hoy M, Fuller B, et al. Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative damage via PI3K/Akt and ERK1/2 MAPK pathways [J]. Lab Invest, 2010, 90(3):391.
[5]
Hsu Y Y, Chen C S, Wu S N, et al. Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron-like cells [J]. Eur J Pharm Sci, 2012, 46(5):415.
[6]
Hsu Y Y, Tseng Y T, Lo Y C. Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth [J]. Toxicol Appl Pharmacol, 2013, 272(3):787.
[7]
Vinik A I, Mitchell B D, Leichter S B, et al. Epidemiology of the complications of diabetes [M]. Cambridge, UK:Cambridge University Press, 1995:221.
Chen Y F, Wang Y W, Zhang J Z, et al. Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance [J]. ISRN Endocrinol, 2011,doi:10.5402/2011/519371.
Yin J, Hu R, Chen M, et al. Effects of berberine on glucose metabolism in vitro[J]. Metabolism, 2002, 51:1439.
[17]
Liong E, Kong S K, Au K K, et al. Inhibition of glucose uptake and suppression of glucose transporter 1 mRNA expression in L929 cells by tumour necrosis factor-alpha[J]. Life Sci, 1999, 65:215.
[18]
Alexandra Cok, Christina Plaisier, Matthew J Salie, et al. Berberine acutely activates the glucose transport activity of GLUT1 [J]. Biochimiestry, 2011, 93:1187.
[19]
Zhou L B, Yang Y, Wang X, et al. Berberine stimulates glucose transport through a mechanism distinct from insulin [J]. Metab Clin Exp, 2007, 56:405.
[20]
Abbud W, Habinowski S, Zhang J Z, et al. Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport[J]. Arch Biochem Biophys, 2000, 380(2):347.
[21]
So Hui Kim, Eun Jung Shin, Eun Do Kim, et al. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes [J]. Biol Pharm Bull, 2007, 30:2120.
[22]
Shen N, Huan Y, Shen Z F. Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic beta-cell [J]. Eur J Pharmacol, 2012, 694(1/3):120.
[23]
Kong W J, Zhang H, Song D Q, et al. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression [J]. Metabolism, 2009, 58(1):109.
[24]
Ahmad F, Azevedo J L, Cortright R, et al. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin -resistant human obesity and diabetes [J]. J Clin Invest, 1997, 100(2):449.
[25]
Ramachandran C, Aebersold R, Tonks N K, et al. Sequential dephosphorylation of a multiply phosphorylated insulin receptor peptide by protein tyrosine phosphatases [J]. Biochemistry, 1992, 31(17):4232.
[26]
Chen C, Zhang Y, Huang C. Berberine inhibits PTP1B activity and mimics insulin action [J]. Biochem Biophys Res Commun, 2010, 397(3):543.
[27]
Liu L Z, Cheung S C, Lan L L, et al. Berberine modulates insulin signaling transduction in insulin-resistant cells [J]. Mol Cell Endocrinol, 2010, 317(1/2):148.
[28]
Oh J H, Ha H, Yu M R, et al. Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis[J]. Kidney Int, 1998, 54(6):1872.
[29]
Liu W, Liu P, Tao S, et al. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose [J]. Arch Biochem Biophys, 2008, 475(2):128.
[30]
Lan T, Wu T, Chen C, et al. Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells:involvement of suppression of cell cycle progression and NF-kappaB/AP-1 pathways [J]. Mol Cell Endocrinol, 2014, 384(1/2):109.
[31]
Wang L, Xing X P, Holmes A, et al. Activati-on of the sphingosine kinase signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells [J]. Circ Res, 2005(97):891.
[32]
Katsuma S, Hada Y, Ueda T, et al. Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation [J]. Genes Cells, 2002,7:1217.
[33]
Lan T, Shen X, Liu P, et al. Berberine ameliorates renal injury in diabetic C57BL/6 mice:involvement of suppression of SphK-S1P signaling pathway [J]. Arch Biochem Biophys, 2010, 502(2):112.
[34]
Paugh B S, Bryan L, Paugh S W, et al. Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells [J]. Biol Chem, 2009, 284:3408.
[35]
Lan T, Liu W, Xie X, et al. Berberine suppresses high glucose-induced TGF-beta1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway [J]. Eur J Pharmacol, 2012, 697(1/3):165.
[36]
Bourne H R, Sanders D A, McCormick F. The GTPase superfamily:a conserved switch for diverse cell functions [J]. Nature, 1990, 348:125.
[37]
Neer E J. Heterotrimeric G proteins:organizers of transmembrane signals [J]. Cell, 1995, 80:249.
[38]
Jang I S, Juhnn Y S. Adaptation of cAMP signaling system in SH-SY5Y neuroblastoma cells following expression of a constitutively active stimulatory G protein alpha, Q227L Gsal-pha [J]. Exp Mol Med, 2001, 33(1):37.
[39]
Salazar N C, Chen J, Rockman H A. Cardiac GPCRs:GPCR signaling in healthy and failing hearts [J]. Biochim Biophys Acta, 2007, 1768:1006.
[40]
Tang L Q, Wang F L, Zhu L N, et al. Berberine ameliorates renal injury by regulating G proteins-AC-cAMP signaling in diabetic rats with nephropathy [J]. Mol Biol Rep, 2013, 40(6):3913.
[41]
Tamura K, Nyui N, Tamura N, et al. Mechanism of angiotensin Ⅱ-mediated regulation of fibronectin gene in rat vascular smooth muscle cells [J]. Biol Chem, 1998, 273:26487.
[42]
Weigert C, Sauer U, Brodbeck K, et al. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells [J]. Am Soc Nephrol, 2000, 11:2007.
[43]
Lan T, Shen X Y, Liu P Q, et al. Berberine ameliorates renal injury in diabetic C57BL/6 mice:involvement of suppression of SphK-S1P signaling pathway [J]. Arch Biochem Biophys, 2010, 502:112.
[44]
Lan T, Liu W H, Xie X, et al. Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells [J]. Mol Endocrinol, 2011, 25:2094.
[45]
Liu W H, Lan T, Xie X, et al. S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition [J]. Exp Cell Res, 2012, 318:936.
[46]
Huang K, Liu W, Lan T, et al. Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models [J]. PLoS ONE, 2012, 7(8):1.
[47]
Xie X, Peng J, Chang X, et al. Activation of RhoA/ROCK regulates NF-kappaB signaling pathway in experimental diabetic nephropathy [J]. Mol Cell Endocrinol, 2013, 369(1/2):86.
[48]
Xie X, Chang X, Chen L, et al. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling [J]. Mol Cell Endocrinol, 2013, 381(1/2):56.
Peter Libby, David M Nathan, Kristin Abraham, et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on cardiovascular complications of type 1 diabetes mellitus[J]. Circulation, 2005, 111:3489.
[51]
Ask-Madsen C, King G L. Mechanisms of disease:endothelial dysfunction in insulin resistance and diabetes [J]. Nat Clin Pract Endocrinol Metab, 2007, 3:46.
Wang Y Q, Huang Y, Karen S L L, et al. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase [J]. Cardiovasc Res, 2009, 82(3):484.
[54]
Battiprolu P K, Lopez-Crisosto C, Wang Z V, et al. Diabetic cardiomyopathy and metabolic remodeling of the heart [J]. Life Sci, 2013, 92(11):609.
[55]
Isfort M, Stevens S C, Schaffer S, et al. Metabolic dysfunction in diabetic cardiomyopathy [J]. Heart Fail Rev, 2014, 19(1):35.
Chang W, Zhang M, Li J, et al. Berberine improves insulin resistance in cardiomyocytes via activation of 5\'-adenosine monophosphate-activated protein kinase [J]. Metabolism, 2013, 62(8):1159.
[58]
Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics-2006 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [J]. Circulation, 2006, 113(6):85.
[59]
Misao J, Hayakawa Y, Ohno M, et al. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction [J]. Circulation, 1996, 94:1506.
[60]
Nishikawa S, Tatsumi T, Shiraishi J, et al. Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induced apoptosis [J]. Mol Cell Cardiol, 2006, 40:510.
[61]
Chen K K, Li G H, Geng F H, et al. Berberine reduces ischemia /reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats [J]. Apoptosis, 2014, 19:946.
[62]
Wang L H, Li X L, Li Q, et al. Berberine alleviates ischemic arrhythmias via recovering depressed I (to) and I (Ca) currents in diabetic rats [J]. Phytomedicine, 2012, 19(3/4):206.
[63]
Wang L H, Yu C H, Fu Y, et al. Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model [J]. Phytother Res, 2011, 25(1):33.
[64]
Leinninger G M, Russell J W, van Golen C M, et al. Insulin-like growth factor-I regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma [J]. Cell Death Differ, 2004, 11(8):885.
